Glutamine-released ammonia acts as an unprecedented signaling molecule activating lipid production.
Glutamine-released ammonia acts as an unprecedented signaling molecule activating lipid production.
复制标题
DOI:
10.1016/j.gendis.2022.07.017
复制
发表时间:
2023-03
期刊:
影响因子:
6.8
通讯作者:
Guo, Deliang
中科院分区:
文献类型:
--
作者:
Cheng, Chunming;Kelsey, Scott;Guo, Deliang
In healthy humans, ammonia circulates in the bloodstream at a concentration around 11e32 mmol/L. Whether ammonia plays any physiological role has been unknown until a recent report published in Nature Metabolism. 1 Ammonia, long thought to be a toxic waste product of amino acid metabolism, needs to be excreted from the human body as urea. Intriguingly, in this paper, Cheng et al 1 for the first time reported that ammonia is not a waste product; rather, it is an unprecedented signaling molecule tying glucose and glutamine to lipid production in human cells. This study revealed that ammonia released from glutamine triggers a cascade of cellular processes leading to the activation of lipogenesis machinery for lipid production (Fig. 1). This discovery has major implications for developing treatments for human diseases such as cancers and metabolic syndromes, as dysregulated metabolism is a hallmark of these diseases.In eukaryotic cells, lipid synthesis is mainly regulated by sterol regulatory element-binding proteins (SREBPs), a family of transcription factors that contain SREBP-1a,-1c and-2. 2, 3 After synthesis, SREBP precursors (w125 kD) bind to the endoplasmic reticulum (ER) membrane in a complex with SREBP cleavage-activating protein (SCAP) and insulininduced gene protein (Insig), which includes Insig-1 and-2 (ER-resident proteins). Lipids are essential components of cellular membranes, while excessive lipids, such as fatty acids and cholesterol, causes toxicity for cells. Therefore, SREBP transcriptional activity and lipid production rates are tightly controlled. SREBPs first need to exit the ER and translocate to the Golgi apparatus for a sequential cleavage by two proteases (site-1 protease (S1P) and site-2 proteases (S2P)), which release the active N-terminal SREBP forms (w65 kD) that enter into the nucleus to activate lipogenic gene expression. 2, 3 The key step controlling SREBPs’ exit from the ER is regulated by SCAP, which binds to COPII-coated vesicles to transport SREBPs from the ER to the Golgi. However, this step is restricted by the ER-resident protein Insig, which directly binds to SCAP to prevent it from interacting with COPII proteins, thereby spatially restricting the SCAP/SREBP complex to the ER. 2 Thus, the key step for SREBP activation is SCAP escaping from Insig binding. Prior to 2015, understanding of SCAP/
DOI:
10.1186/s40880-018-0301-4
发表时间:
2018-05-21
期刊:
Cancer communications (London, England)
影响因子:
--
作者:
Cheng C;Geng F;Cheng X;Guo D
通讯作者:
Guo D
影响因子:
7.3
作者:
Guo D;Prins RM;Dang J;Kuga D;Iwanami A;Soto H;Lin KY;Huang TT;Akhavan D;Hock MB;Zhu S;Kofman AA;Bensinger SJ;Yong WH;Vinters HV;Horvath S;Watson AD;Kuhn JG;Robins HI;Mehta MP;Wen PY;DeAngelis LM;Prados MD;Mellinghoff IK;Cloughesy TF;Mischel PS
通讯作者:
Mischel PS
影响因子:
20.8
作者:
Cheng, Chunming;Geng, Feng;Li, Zoe;Zhong, Yaogang;Wang, Huabao;Cheng, Xiang;Zhao, Yue;Mo, Xiaokui;Horbinski, Craig;Duan, Wenrui;Chakravarti, Arnab;Cheng, Xiaolin;Guo, Deliang
通讯作者:
Guo, Deliang